Exhibiting at Middle East Poultry Expo 2025

China Animal Husbandry Industry Co., Ltd. (CAHIC), headquartered in Beijing, China, is one of the country’s largest and most established manufacturers of veterinary biologicals, pharmaceuticals, and animal nutrition products. Founded under the umbrella of China National Agricultural Development Group, CAHIC plays a pivotal role in the nation's animal health and husbandry ecosystem and serves a global clientele in over 50 countries.

Core Business

CAHIC operates across multiple verticals within the animal health industry, including the development, production, and export of veterinary vaccines, diagnostic reagents, veterinary drugs, and animal nutrition products. The company also actively engages in the trading of raw materials for feed and veterinary pharmaceuticals.

Product and Service Offerings

• Biological Products

  • Inactivated and live veterinary vaccines for poultry, swine, and ruminants
  • Diagnostic reagents for disease detection and immunity testing

• Veterinary Drugs

  • Broad-spectrum antibiotics
  • Antiparasitic and anthelmintic drugs
  • Antiviral formulations and immunostimulants

• Animal Nutrition Products

  • Feed Additives and Multivitamin Premixes
  • Amino Acids and Organic Mineral Premixes
  • Probiotics and Digestive Enzyme Blends

• Raw Material Trading

  • Bulk supply of feed ingredients
  • API trading for veterinary pharmaceutical production

Specialization and Core USP

CAHIC is uniquely positioned with a vertically integrated business model combining R&D, production, distribution, and raw material trading. The company’s R&D platform includes state-certified biosafety labs, GMP-certified production lines, and a national veterinary vaccine engineering research center. Its proprietary CAVac brand is recognized across Asia and Africa for efficacy and reliability.

Financial Overview

CAHIC’s annual revenue exceeds RMB 2.5 billion (~USD 350 million), with exports contributing approximately 30% of total sales. The company is publicly traded under the ticker “600195” on the Shanghai Stock Exchange, indicating strong investor confidence and market performance.

Shipment Data

According to export data from ImportYeti and Volza:

• Over 1,000 containers shipped globally per year
• Export destinations include Southeast Asia (Vietnam, Indonesia), Africa (Nigeria, Kenya), and South America (Peru, Ecuador)
• Leading products in demand: Avian influenza vaccines, Newcastle disease vaccines, multivitamin premixes

Target Market

CAHIC serves:

• Poultry, swine, and cattle farms
• Government veterinary health agencies
• Distributors and veterinary clinics
• Feed manufacturers and integrators
• International NGOs involved in livestock health programs

Capabilities

• R&D Strength: 6 R&D centers, 20+ research patents, and national-level key laboratories
• Production Scale: Multiple GMP-certified factories producing billions of vaccine doses annually
• Workforce: Over 2,000 employees including 300+ researchers and veterinary specialists
• International Distribution: Strong network of partners and agents in over 50 countries

Certifications and Compliance

• GMP Certification – Multiple veterinary drug and vaccine production lines
• ISO 9001 & ISO 14001 – Quality and Environmental Management Systems
• OIE and FAO Collaborations – Recognized for disease eradication programs and vaccination campaigns
• Halal Certification – For select veterinary pharmaceutical products

Customer Testimonials

Distributors from Egypt and Uganda have commended the company’s consistency in vaccine efficacy and timely shipment logistics. A leading poultry group in Indonesia reported a 40% reduction in mortality rates after switching to CAHIC’s comprehensive immunization program.

Major Achievements

• Developed China’s first inactivated Avian Influenza H9N2 vaccine
• Recognized as a National High-Tech Enterprise by the Ministry of Science and Technology
• Key supplier for China’s national reserve of animal vaccines
• Won multiple awards at VIV China, EuroTier, and World Poultry Congress
• Launched proprietary diagnostic platform for real-time livestock disease monitoring